Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Curr Drug Saf ; 17(3): 281-283, 2022.
Article in English | MEDLINE | ID: mdl-34809550

ABSTRACT

BACKGROUND: DIGO or drug-induced gingival overgrowth occurs as a side effect of certain drugs. Until now, the etiology of drug-induced gingival overgrowth is not clearly understood. Among the calcium channel blockers, nifedipine has been shown to be most frequently associated with drug-induced gingival hyperplasia. Amlodipine is a comparatively newer calcium channel blocker that with a longer duration of action and lesser side effects as compared to nifedipine. There are only certain case reports of amlodipine-induced gum hyperplasia. CASE PRESENTATION: We report a case of amlodipine-induced gum hyperplasia in a 66-year-old hypertensive patient taking amlodipine at a dose of 5 mg once a day. There was significant regression of gum hypertrophy after substitution of amlodipine by Losartan. CONCLUSION: Amlodipine is one of the commonly prescribed antihypertensive drugs, and gingival hyperplasia is one overlooked side effect in patients taking amlodipine. Awareness of this potential side effect of amlodipine may be helpful to reduce the anxiety of patients and the cost of diagnostic procedures.


Subject(s)
Gingival Hyperplasia , Gingival Overgrowth , Aged , Amlodipine/adverse effects , Calcium Channel Blockers/adverse effects , Gingival Hyperplasia/chemically induced , Gingival Overgrowth/chemically induced , Humans , Hyperplasia/chemically induced , Hypertrophy/chemically induced , Nifedipine/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...